Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

2.

Cancer detection recovered following pandemic disruptions

3.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

4.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

5.

Survivors of childhood brain cancer are more likely to be held back in school


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot